Introduction: The evidence on the association of fish or omega-3 fatty acid intake
| MATERIALS AND METHODS

| Search strategy
Studies were identified by a literature search of PubMed and Web of Science, for articles published up to April 2018. The following keywords were used in searching: "(fish, omega-3, n-3, or ω-3) combined with (depression, depressive symptom, or depressive disorder)." Furthermore, the reference lists of original and review articles were searched to identify for additional eligible studies. All searches were limited to human studies published in English.
| Study selection
Studies were included in this meta-analysis if they met the following criteria: (1) studies that presented original data from prospective cohort studies; (2) the outcome of interest was depression, excluding postpartum depression and depression in pregnancy. If a study provided combined data on depression and anxiety, it was not included (Sanchez-Villegas et al., 2007) ; (3) the exposure of interest was fish or omega-3 fatty acid intake; (4) the participants of interest were from the general adult population. Studies conducted in patients who had specific disease were not included; and (5) studies that provided odds ratio or risk ratio with 95% confidence interval (CI) for intakes of fish or omega-3 fatty acids. Individual prospective cohort studies were approved by Ethics Committee and Institutional Review Board of their institutions. Written informed consent was obtained from the subjects who participated in the studies.
| Data extraction
Two reviewers (Y.Y. and Y.K.) extracted data according to the checklist of the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines (Stroup et al., 2000) . We extracted the following information from each study: the first author's name, publication year, length of follow-up, country or region, age, proportion of men, number of subjects and cases, dietary intake assessment, outcome measurement, categories of fish consumption or omega-3 fatty acid intake, adjustment factors, and relative risk (RR) with 95% CIs of depression for each category of fish or omega-3 fatty acid intakes. We used the RRs from multivariable models that were the most fully adjusted for potential confounders.
| Assessment of study quality
The Newcastle-Ottawa quality assessment scale (Wells et al., 2018) was used to evaluate the quality of studies with respect to 3 aspects including the selection of participants (0-4 points), the comparability of groups (0-3 points), and outcome ascertainment (0-4 points). Studies scoring ≥8 points were identified as high quality.
| Statistical analysis
We combined the study-specific RRs for the highest vs lowest category of fish or omega-3 fatty acid intake from observational studies using DerSimonian and Laird random-effects models, which incorporate both within-study and between-study variations (DerSimonian & Laird, 2015) . If the original studies had not used the lowest category as a reference, the RR and its 95% CI were recalculated (Li et al., 2011) . If the original studies reported both an overall RR and sex-specific RRs (Colangelo et al., 2009) , we used the overall RR in the main analysis. For the meta-analysis by sex, however, the sex-specific RRs were used. When studies reported results from both alpha-linolenic acid (ALA) + eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) + docosapentaenoic acid (DPA) and EPA+DHA+DPA, we used the latter one because ALA is derived from plants (Hakkarainen et al., 2004; Kesse-Guyot et al., 2012; Persons et al., 2014) . The summary RRs and 95% CIs were presented as forest plots, where the size of data markers (squares) corresponds to the inverse of the variance of the natural logarithm of RR from each study and the diamond indicates a pooled RR. Dose-response meta-analyses of fish consumption or omega-3 fatty acids and risk of depression were conducted by using generalized least squares trend estimation, according to the methods proposed by Greenland, Longnecker, and colleagues (Berlin, Longnecker, & Greenland, 1993; Greenland & Longnecker, 1992; Orsini, Bellocco, & Greenland, 2006) . We used the 2-stage generalized least squares trend estimation method to estimate the study-specific slope lines first and then obtain an overall average slope. We calculated the RR for 1 serving/week increment of fish consumption and 500 mg/day increment of omega-3 fatty acid intake. For the study that reported results for fish consumption in terms of g/day only (Matsuoka et al., 2017) , we supposed that 100 g of fish equals 1 serving as has been done in a previous study of fish consumption (Bouzan et al., 2005; Guevel, Sirot, Volatier, & Leblanc, 2008; Wu et al., 2015) . For the analysis of fish consumption, 3 studies were excluded due to insufficient information on the number of cases, number of controls, and exposure categories (Colangelo et al., 2009; Hakkarainen et al., 2004; Lucas et al., 2011) , and 3 studies with fewer than 3 exposure categories were also excluded (Mihrshahi et al., 2015; Smith et al., 2014; Tsai et al., 2012) . For the analysis of omega-3 fatty acid intake, 2 studies were excluded because of insufficient information on the number of cases, number of controls, and exposure categories (Colangelo et al., 2009; Hakkarainen et al., 2004) .
Q statistic (Cochran, 1954) was used to assess statistical heterogeneity, and inconsistency was quantified using I 2 statistic (Higgins, Thompson, Deeks, & Altman, 2003) . For the Q statistic, heterogeneity was considered as P < 0.05. To test for variations in risk estimates among the studies, we conducted subgroup analyses stratified by sex, geographic region (USA, Australia, Asia, and Europe for fish;
Europe, USA, and Asia for omega-3 fatty acids), the number of subjects (lower or higher number of subjects than the median), length of RRs of the subgroups. Sensitivity analyses were conducted by omitting 1 study at a time to examine the influence of each individual study on the overall RR. Finally, publication bias was assessed by Begg and Mazumdar's test (Begg & Mazumdar, 1994 ) and Egger's regression test (Egger, Smith, Schneider, & Minder, 1997 3 | RESULTS
| Study characteristics
Our search identified 4977 related articles, of which 1497 duplicates and 3421 irrelevant articles were removed. After excluding duplicated and irrelevant articles, 10 prospective studies met our inclusion criteria. The 10 prospective studies included 109 764 participants, with 6672 cases (Colangelo et al., 2009; Hakkarainen et al., 2004; Kesse-Guyot et al., 2012; Li et al., 2011; Lucas et al., 2011; Matsuoka et al., 2017; Mihrshahi et al., 2015; Persons et al., 2014; Smith et al., 2014; Tsai et al., 2012) (Figure 1 ). The characteristics of prospective studies included in the meta-analysis are presented in Table 1 . The smallest sample size was 1181 participants (Matsuoka et al., 2017) , while the largest sample size was 54 632 participants (Lucas et al., FIGURE 1 Flow chart of the selection of studies included in the meta-analysis 
2011). Of the 10 prospective studies, 4 studies examined the association of both fish and omega-3 fatty acid intake and depression (Colangelo et al., 2009; Hakkarainen et al., 2004; Lucas et al., 2011; Matsuoka et al., 2017) , 4 studies were focused only on fish consumption (Li et al., 2011; Mihrshahi et al., 2015; Smith et al., 2014; Tsai et al., 2012) , and 2 studies were focused only on omega-3 fatty acid intake (Kesse-Guyot et al., 2012; Persons et al., 2014) . The participants were all adults at baseline. With regard to sex, 6 studies included both male and female subjects (Colangelo et al., 2009; Kesse-Guyot et al., 2012; Li et al., 2011; Matsuoka et al., 2017; Smith et al., 2014; Tsai et al., 2012) , and 4 studies included male (Hakkarainen et al., 2004) or female (Lucas et al., 2011; Mihrshahi et al., 2015; Persons et al., 2014 ) subjects only. By geographic region, 2 studies were conducted in Europe (Hakkarainen et al., 2004; Kesse-Guyot et al., 2012) , 4 in America (Colangelo et al., 2009; Li et al., 2011; Lucas et al., 2011; Persons et al., 2014) , 2 in Asia (Matsuoka et al., 2017; Tsai et al., 2012) , and 2 in Australia (Mihrshahi et al., 2015; Smith et al., 2014) . Dietary assessment was measured by using Food Frequency Questionnaires (FFQ) (Colangelo et al., 2009; Hakkarainen et al., 2004; Li et al., 2011; Lucas et al., 2011; Matsuoka et al., 2017; Mihrshahi et al., 2015; Persons et al., 2014; Smith et al., 2014; Tsai et al., 2012) or 24-h dietary recalls (Kesse-Guyot et al., 2012) . Most of the studies defined depression using the Centre for Epidemiologic
Depression Scale (CES-D) which has been the most commonly used (Colangelo et al., 2009; Kesse-Guyot et al., 2012; Li et al., 2011; Matsuoka et al., 2017; Mihrshahi et al., 2015; Tsai et al., 2012) . All studies were adjusted for smoking. The study by Smith et al. adjusted for smoking only in females. Most of the studies provided risk estimates that were adjusted for alcohol (Colangelo et al., 2009; Hakkarainen et al., 2004; Kesse-Guyot et al., 2012; Li et al., 2011; Lucas et al., 2011; Matsuoka et al., 2017; Mihrshahi et al., 2015; Persons et al., 2014; Tsai et al., 2012) , physical activity (Colangelo et al., 2009; Kesse-Guyot et al., 2012; Lucas et al., 2011; Matsuoka et al., 2017; Mihrshahi et al., 2015; Persons et al., 2014; Tsai et al., 2012) , and BMI (Colangelo et al., 2009; Hakkarainen et al., 2004; KesseGuyot et al., 2012; Li et al., 2011; Lucas et al., 2011; Mihrshahi et al., 2015) . The results of quality assessment yielded a score of 8 points or above for all studies, indicating high quality.
| Pooled relative risk of high vs low intakes
The multivariable-adjusted RRs for each study and all prospective studies combined for the highest vs lowest categories of fish consumption are shown in Figure 2 . Ten prospective studies examined the association between fish consumption and risk of depression. and ≥2534 subjects were 0.82 (95% CI: 0.66-1.02) and 0.94 (95% CI: 0.82-1.08), respectively (P for difference = 0.254). For the followup length, we used a median follow-up time of 9 years as a cutoff.
The pooled RRs for short and long follow-up periods were 0.89 (95% CI: 0.78-1.02) and 0.88 (95% CI: 0.72-1.08), respectively (P for difference = 0.971). When we conducted a stratified analysis by participant's age (≤60 vs >60 years), the results were similar (P for difference = 0.859). For the analysis stratified by outcome measure, the pooled RRs for CES-D and other diagnostic methods of depression were 0.87 (95% CI: 0.76-1.01) and 0.93 (95% CI: 0.77-1.14), respectively (P for difference = 0.653). 
| Dose-response analyses
Three prospective studies were included for the dose-response analysis of fish consumption and risk of depression (Table 2 ). In a doseresponse meta-analysis for 1 serving/week increment in fish
Relative Risk (95% CI)
FIGURE 3 Forest plot of depression for the highest vs lowest categories of omea-3 fatty acid intake consumption and depression risk, we found a pooled RR of 0.89 (95% CI: 0.75-1.04), with no significant heterogeneity (P = 0.109, I 2 = 54.8%).
Four prospective studies were included for the dose-response analysis of intake of omega-3 fatty acids and risk of depression. In a doseresponse meta-analysis for 500 mg/day increment in omega-3 fatty acid intake, we found a pooled RR of 0.99 (95% CI: 0.94-1.04), with no significant heterogeneity (P = 0.885, I 2 = 0.0%) (Table 3) .
| Publication bias
For the meta-analysis of the highest category vs the lowest, there was no indication of publication bias for fish consumption (Begg's P > 0.99;
Egger's P = 0.42) or omega-3 fatty acid intake (Begg's P > 0.99; Egger's P = 0.94). For the dose-response meta-analysis, we also found no evidence of publication bias for 1 serving/week increment in fish consumption (Begg's P = 0.30; Egger's P = 0.19) or 500 mg/day increment in omega-3 fatty acid intake (Begg's P = 0.31; Egger's P = 0.13).
| DISCUSSION
To quantitatively assess the association of fish consumption or omega-3 fatty acid intake with risk of depression, we conducted a meta-analysis of 10 prospective studies. Our results suggest that fish consumption was associated with a lower risk of developing depression, although there was not a strong dose-response relationship.
We found a 11% lower risk of depression in people with high fish consumption compared to those with low consumption category. People with high intake of omega-3 fatty acids had a 13% lower risk of depression compared to those with low intake, but the result was not significant. Among women, a significantly decreased risk of depression was found in women who consumed high omega-3 fatty acids. These findings were consistent with those from previous meta-analysis on fish consumption or omega-3 fatty acid intake and risk of depression, suggesting the existence of an inverse association (Grosso, Micek, Marventano, et al., 2016; . There was no evidence of heterogeneity among the studies in the analysis of high fish or omega-3 fatty acid intake vs low intake, and the dose-response analyses of fish and omega-3 fatty acid intake.
Of the 10 studies included in the current meta-analysis, 1 study reported a beneficial effect of fish on depression in women but not in men (Smith et al., 2014) . The longitudinal study from Australia reported that women who ate fish ≥2 times/week had a significantly lower depression than those who ate fish <2 times/week (RR = 0.75, 95% CI: 0.57-0.99), while for men, depression was not associated with fish consumption (RR = 1.17, 95% CI: 0.74-1.86) during about 5-year follow-up. A prospective cohort study including 5068 Americans reported that men who ate fish less than once per week had a significantly higher depression than those who ate fish more than once per week (OR = 2.08, 95% CI: 1.08-4.09) (Li et al., 2011) . Overall, our meta-analysis showed that the inverse association tended to be stronger for women, which may be due to the effects of sex hormones. A strong stimulus with estrogens causes DHA levels to increase, whereas a testosterone stimulus causes a decrease in DHA. Thus, DHA biosynthesis might be greater in women than in men (Giltay, Gooren, Toorians, Katan, & Zock, 2004) .
In subgroup analyses, we found a significant inverse association with EPA and DHA. The association tended to be slightly stronger for EPA than for DHA. Eicosapentaenoic acid may inhibit inflammation by suppressing production of proinflammatory cytokines, which are known to increase the risk for the development of depression (Bhattacharya, Sun, Rahman, & Fernandes, 2007; Heller et al., 1998; Valkanova et al., 2013 ). An Italian study found that omega-3 fatty acid concentrations were associated with lower levels of proinflammatory markers and higher levels of antiinflammatory markers (Ferrucci et al., 2006) . Eicosapentaenoic acid is more potent in reducing proinflammatory cytokine production and, thus, may be more antiinflammatory than DHA (Bhattacharya et al., 2007; Sierra et al., 2008) . However, the findings from these subgroup analyses should be interpreted with caution, given the small number of studies that involved subgroup analyses.
A prospective study evaluating fish consumption or omega-3 fatty acid intake with the incidence of mental disorders was not included because the mental disorder was defined as depression, anxiety or stress, or use of antidepressant medication or tranquilizers (SanchezVillegas et al., 2007) . As we mentioned above, we included studies that the outcome of interest was depression. The prospective study (the SUN cohort), including 7903 participants, suggested a potential beneficial effect of fish or omega-3 fatty acid intake on total mental disorders, although no linear trend was evident. A study which included the use of lithium as an indication of depression was also excluded from our study (Astorg et al., 2008) . Lithium treatment was associated with a reduced risk of relapse in bipolar disorder (Geddes, Burgess, Hawton, Jamison, & Goodwin, 2004) . The study, conducted in France, reported that consumption of fatty fish or an intake of more than 0.1% of total energy as long-chain omega-3 fatty acids was inversely associated with risk of depression (Astorg et al., 2008) .
In addition to prospective studies, many cross-sectional studies examined the association between fish consumption or omega-3 fatty acid intake and depression (Albanese et al., 2012; Barberger-Gateau et al., 2005; Beydoun et al., 2013; Bountziouka et al., 2009; Chrysohoou et al., 2011; Daley, Patterson, Sibbritt, & MacDonaldWicks, 2015; Hamazaki et al., 2015; Hoffmire, Block, Thevenet-Morrison, & van Wijngaarden, 2012; Jacka et al., 2013; Kamphuis et al., 2006; Kesse-Guyot et al., 2012; Mihrshahi et al., 2015; Murakami et al., 2008; Suominen-Taipale et al., 2010; Supartini, Oishi, & Yagi, 2017; Tanskanen et al., 2001; Timonen et al., 2004; Wu et al., 2016; . Most of the studies reported significant inverse associations between fish consumption and depression (Barberger-Gateau et al., 2005; Bountziouka et al., 2009; Chrysohoou et al., 2011; Hamazaki et al., 2015; Supartini et al., 2017; Suominen-Taipale et al., 2010; Tanskanen et al., 2001; Timonen et al., 2004; Wu et al., 2016) , and some of the studies showed strong inverse associations, suggesting more than 50% decreased prevalence of depression for people with high fish consumption (Albanese et al., 2012; Chrysohoou et al., 2011; Suominen-Taipale et al., 2010; Supartini et al., 2017; Timonen et al., 2004) . Studies evaluating omega-3 fatty acid intake and depression also mostly found significant or nonsignificant inverse associations between omega-3 fatty acid intake and the prevalence of depression (Beydoun et al., 2013; Hoffmire et al., 2012; Kamphuis et al., 2006; Kesse-Guyot et al., 2012; Murakami et al., 2008) . For clinical trials, there were no studies conducted to examine the effect of omega-3 fatty acid intake or fish consumption on risk of depression in subjects who were free of depression. However, many clinical trials were conducted to assess the treatment effect of omega-3 fatty acid intake on depressive patients. The results from 19 trials suggested that omega-3 polyunsaturated fatty acid supplementation was effective in patients with depression (Grosso et al., 2014) . These findings were consistent with our results from the current meta-analysis of omega-3 fatty acid intake. For fish consumption, no clinical trials were conducted among depressive patients.
The effects of fish or omega-3 fatty acids on depression may be explained by several potential mechanisms. Omega-3 fatty acids, which are rich in fish, may exert its influence on the depression through its effects on the neurotransmission system. Deficiency in dietary ALA, the precursor of long-chain omega-3 fatty acids, could induce an increase in serotonin 2 (5-HT 2 ) and decrease in dopamine 2 (D 2 ) receptor density in the frontal cortex (Delion et al., 1994) . Several studies have reported an increased density of postsynaptic 5-HT 2 receptor binding sites in the frontal cortex from depressed suicide victims (Arora & Meltzer, 1989; Stanley & Mann, 1983) . Among healthy subjects, high plasma concentration of omega-3 fatty acids was associated with higher levels of cerebrospinal fluid 5-hydroxyindoleacetic acids (CSF 5-HIAA), which is a metabolite of serotonin turnover (Hibbeln et al., 1998) . In addition, a recent meta-analysis indicated that oxidative stress markers were increased in depression (Black et al., 2015) . In an animal study on relationship between omega-3 fatty acids and oxidative stress, the findings suggested that oxidative stress can be attenuated by high levels of EPA and DHA (Saada et al., 2014) .
Moreover, a meta-analysis of case-control studies comparing the levels of polyunsaturated fatty acids between depressed and nondepressed participants found that the levels of DHA, EPA, and total omega-3 fatty acids were lower in depressed participants (Lin, Huang, & Su, 2010) .
There are some strengths in our study. First, to the best of our knowledge, this is the most up-to-date comprehensive study on the association of fish or omega-3 fatty acid intakes with risk of depression.
Moreover, we included only prospective studies, which can minimize the possibility of methodological biases such as recall bias and selection bias inherent in retrospective studies. Second, we conducted various subgroup analyses to assess whether the associations varied by several factors including sex, geographical region, and type of omega-3 fatty acids. However, many RRs are nonsignificant in the subgroup analyses, which might be due to the small number of studies included in the subgroup analyses. Third, we also explored the effect of fish or omega-3 acid intakes on the risk of depression by carrying out dose-response analyses. Finally, we found no evidence of publication bias, which could be of concern in meta-analyses. Despite these strengths, our study has several limitations. First, although most of the studies adjusted for potential confounding factors such as smoking and alcohol consumption, we cannot rule out the possibility of residual confounding, because our meta-analysis was based on observational studies. Second, the measurement of dietary intake and diagnosis of depression were not consistent among the studies included in the meta-analysis.
Nevertheless, the overall findings of fish consumption or omega-3 intake on risk of depression showed no significant heterogeneity among the studies. Finally, papers not published in English have not been included, and therefore, some studies may have been missed.
In conclusion, our findings provide quantitative evidence for a modest inverse association between fish or omega-3 fatty acid intake and risk of depression, especially in women. These findings from the observational studies need to be confirmed through large randomized clinical trials of fish consumption or omega-3 fatty acid intake and risk of depression.
